Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Side effects are usually mild and resolve within days
In the multicenter SURMOUNT trial, a 72-week treatment with tirzepatide, a dual GLP-1R/GIPR agonist, resulted in a 20.9% reduction in body weight17.7% greater than that observed in the placebo group
This content is provided strictly for research purposes and does not constitute an endorsement or recommendation for the non-laboratory application or improper handling of peptides designed for research
Este efecto ocurre sin necesidad de exposicin prolongada a radiacin ultravioleta, aunque la luz puede potenciarlo
US$ 26.51
US$ 20.82
US$ 24.94
US$ 22.93
US$ 24.07
